You can also explore a wide range of diabetes-related products and weight loss solutions like Mounjaro, Ozempic and more at Fit Life Pharmacy for all your health and wellness needs. Whether you’re looking for additional monitoring tools, supplements, or support for weight management, we offer top-quality products designed to enhance your lifestyle and health. Visit us today to find everything you need to stay on track with your health goals!
- “Basaglar Cartridges 100 Units / mL” already exists in your wishlist
Basaglar Cartridges 100 Units / mL
Roll over image to zoom in
$107.91 – $398.34
Basaglar Cartridges contain long-acting insulin glargine, designed to provide steady 24-hour blood sugar control for people with type 1 or type 2 diabetes. Compatible with insulin pen devices, these cartridges offer flexible, precise dosing for once-daily insulin therapy. Basaglar helps support consistent glucose management as part of a long-term diabetes care plan.
Basaglar Cartridges – Reliable Once‑Daily Basal Insulin for Consistent, 24‑Hour Blood Sugar Control
Managing diabetes effectively requires more than just medication—it demands a therapy that mimics the body’s natural insulin patterns, fits seamlessly into daily life, and provides predictable, stable blood sugar levels. Basaglar Cartridges deliver long‑acting insulin glargine U‑100 in a pre‑filled, cartridge format compatible with reusable insulin pens, offering once‑daily dosing that sustains both fasting and between‑meal glucose control. At Fit Life Pharmacy, we’re proud to provide Basaglar Cartridges as an affordable, proven basal insulin solution—backed by patient education, personalized titration support, and cost‑saving resources.
Understanding Basal Insulin and Basaglar’s Role
In non‑diabetic individuals, the pancreas continuously secretes low‑level insulin (“basal”) to regulate hepatic glucose production and maintain euglycemia between meals and overnight. This basal insulin prevents fasting hyperglycemia. In type 1 and type 2 diabetes, endogenous basal secretion is diminished or absent, necessitating exogenous basal insulin therapy.
Basaglar Cartridges are designed to replicate that natural, flat basal insulin profile. By providing a consistent background of insulin without pronounced peaks, Basaglar Cartridges helps:
- Suppress unregulated hepatic glucose output
- Maintain steady fasting glucose levels (80–130 mg/dL)
- Minimize glycemic variability that contributes to long‑term complications
In clinical practice, reliable basal coverage is the cornerstone of a basal‑bolus regimen, laying the foundation for adding rapid‑acting insulin at mealtimes.
What Are Basaglar Cartridges?
Basaglar Cartridges are pre‑filled insulin cartridges containing insulin glargine at 100 units/mL (U‑100). Each cartridge holds 3 mL (300 units) of insulin and is compatible with reusable pen injectors designed for U‑100 cartridges, such as the FlexPen® and other pen systems. By combining the precision of cartridge dosing with the flexibility of pen delivery, Basaglar Cartridges offer:
- Accurate dosing in 1‑unit increments
- A maximum single‑dose capacity up to 80 units
- A pre‑filled format that eliminates drawing up insulin from a vial
- Seamless insertion and removal, reducing waste and mess
This cartridge system provides the benefits of pen delivery—ease of use, portability, and dosing confidence—while allowing patients to use their preferred reusable pen devices.
Mechanism of Action: Building a Subcutaneous Depot
Upon subcutaneous injection—commonly into the abdomen, upper arm, or thigh—insulin glargine molecules form microscopic precipitates due to their slightly acidic formulation. As these microcrystals dissolve slowly at physiological pH, small amounts of insulin glargine are released continuously into the capillary network over a 24‑hour period. This mechanism yields:
- A nearly constant insulin level with minimal peak
- Predictable absorption, reducing day‑to‑day variability
- Smoother basal insulin action compared to intermediate‑acting insulins
By providing a flat, peak‑less profile, Basaglar Cartridges help maintain consistent glucose control overnight and between meals, minimizing both hyperglycemic excursions and hypoglycemic events.
Clinical Benefits of Basaglar Cartridges
Patients and clinicians choose Basaglar Cartridges for their proven ability to improve long‑term outcomes and quality of life. Key clinical benefits include:
Improved Glycemic Control
Large randomized trials demonstrate that Basaglar Cartridges produces HbA1c reductions comparable to branded insulin glargine (Lantus®), with sustained fasting glucose improvements over 6–12 months.
Reduced Hypoglycemia Risk
Basaglar’s flat action curve is associated with a lower incidence of nocturnal hypoglycemia compared to intermediate‑acting insulins, enhancing patient safety and confidence in basal dosing.
Enhanced Adherence and Satisfaction
The cartridge‑pen combination simplifies injection routines. Studies show that pen delivery systems improve adherence rates, reduce dosing errors, and garner higher patient satisfaction compared to vial‑and‑syringe regimens.
Cost‑Effective Therapy
As a biosimilar offering equivalent clinical outcomes at a lower list price, Basaglar Cartridges help patients and health systems manage budgets without compromising efficacy.
Detailed Product Features
| Feature | Specification |
|---|---|
| Active Ingredient | Insulin glargine U‑100 |
| Cartridge Volume | 3 mL (300 units) |
| Dosing Increments | 1 unit |
| Maximum Single Injection | 80 units |
| Onset of Action | 1–2 hours |
| Peak | Minimal (peak‑less profile) |
| Duration | Up to 24 hours |
| Storage (Unopened) | Refrigerate at 36–46 °F (2–8 °C); do not freeze |
| Storage (In‑Use) | Room temperature ≤ 86 °F (≤ 30 °C) for up to 28 days |
| Compatible Injection Sites | Abdomen, thigh, upper arm |
| Injection Angle | 90° subcutaneous |
| Disposal | Discard needles in an FDA‑approved sharps container |
These features ensure that every cartridge delivers a consistent, predictable dose of basal insulin, with minimal preparation and maximum dosing accuracy.
Comprehensive Administration Guide
Inspecting and preparing a Basaglar Cartridge requires attention to detail to ensure safety and efficacy:
Visual Inspection
Always check the expiration date. Verify that the insulin solution is clear and colorless. Discard any cartridge that appears cloudy, contains particles, or is discolored.
Pen Preparation
Insert the cartridge into your reusable pen following the manufacturer’s instructions. Attach a new, sterile pen‑needle securely.
Priming
Dial 2 units and hold the pen upright. Press the injection button until a drop of insulin appears at the needle tip. This step removes air bubbles and primes the needle for accurate dosing.
Setting the Dose
Turn the dose selector until the prescribed number of units aligns with the dose window. Each audible click corresponds to 1 unit.
Injection Site Preparation
Rotate injection sites to prevent lipodystrophy. Clean the chosen area with an alcohol swab, allowing it to air‑dry fully before injection.
Injection Technique
Pinch a small fold of skin, insert the needle at a 90° angle, and press the injection button in one smooth motion. Hold the needle in place for at least 6 seconds to ensure the entire dose is delivered before withdrawing.
Needle Disposal and Pen Storage
Remove and discard the needle in an FDA‑approved sharps container. Recap the pen and store at room temperature (≤ 86 °F/≤ 30 °C) away from direct heat or light.
Personalizing Your Basaglar Cartridges Regimen
Effective basal therapy demands individualized dosing, titration, and monitoring:
Initiation Dosing
In type 1 diabetes, total daily insulin requirements are approximately 0.5–0.8 units/kg. Basal comprises ~ 50% of total daily dosage. In type 2 diabetes, initiation often begins at 0.2 units/kg once daily, with adjustments based on fasting glucose targets.
Titration Protocol
Aim for fasting glucose levels between 80 and 130 mg/dL. Adjust basal dose by 2–4 units every 3–4 days, guided by morning glucose readings. Decrease dose if hypoglycemia (< 80 mg/dL) occurs.
Split‑Dose Considerations
While once‑daily dosing covers most patients, some individuals—especially those with pronounced dawn phenomenon—may benefit from twice‑daily injections spaced 12 hours apart to achieve more uniform coverage.
Carbohydrate Consistency and Bolus Integration
Basal insulin addresses fasting and background needs. Coordinate with rapid‑acting insulin for mealtime coverage. Consistent carbohydrate intake supports basal dose stability. Carbohydrate counting and insulin‑to‑carb ratios help determine bolus doses.
Integrating Basaglar Cartridges into Daily Life
Ensuring consistent basal coverage requires aligning injection timing and lifestyle factors:
Routine and Reminders
Administer Basaglar Cartridges at the same time each day—often at bedtime or with the evening meal—to match its 24‑hour profile. Use alarms, smartphone apps, or calendar reminders to stay on schedule.
Exercise and Activity
Physical activity increases insulin sensitivity. Monitor glucose before and after exercise and adjust basal dose or carbohydrate intake accordingly to prevent hypoglycemia.
Travel Considerations
Unopened cartridges must be refrigerated during travel. In‑use cartridges can be kept at room temperature (≤ 86 °F/≤ 30 °C) for up to 28 days. Use insulated carriers in extreme climates and avoid freezing or excessive heat.
Dietary and Alcohol Impact
Basal insulin is intended for background control. Maintain consistent meal patterns and consider the effects of alcohol—especially in the evening—on overnight glucose stability.
Technology Integration: Smart Pens and Data Tools
Advancements in diabetes technology enhance basal insulin management:
Smart Pen Adapters
Attach electronic caps or sleeves that record date, time, and dosage, syncing with mobile apps to eliminate manual logging.
Continuous Glucose Monitoring (CGM)
Real‑time glucose data provide insights into basal coverage efficacy, revealing nocturnal trends and informing titration decisions.
Diabetes Management Platforms
Integrated software aggregates insulin delivery, CGM data, and carbohydrate logs, enabling remote provider oversight and data‑driven adjustments.
These tools empower patients and clinicians to refine basal dosing with precision and minimize guesswork.
Special Populations and Safety Considerations
Pediatrics
Basaglar Cartridges are indicated for children aged 2 and older. Pediatric dosing requires careful adjustment by a specialist, accounting for growth, activity, and nutritional needs.
Elderly
Older adults may exhibit decreased renal and hepatic function, heightening hypoglycemia risk. Lower starting doses (0.1–0.2 units/kg) and slower titration minimize adverse events.
Pregnancy
Insulin glargine is frequently used in gestational diabetes under obstetric supervision. Doses often increase across trimesters due to rising insulin resistance. Frequent glucose monitoring is essential.
Renal and Hepatic Impairment
Reduced insulin clearance may necessitate lower basal doses and more frequent monitoring to avoid hypoglycemia.
Clinical Evidence and Real‑World Outcomes
Basaglar’s efficacy and safety are supported by robust clinical and observational data:
Efficacy Trials
Randomized studies demonstrate A1c reductions equivalent to branded insulin glargine (Lantus) over 24–52 weeks in type 1 and type 2 diabetes, with similar hypoglycemia profiles.
Real‑World Registries
Patient registries show high adherence rates with cartridge‑based pens, improved patient satisfaction, and fewer missed basal doses compared to vial/syringe methods.
Cost‑Effectiveness Analyses
As a lower‑cost biosimilar, Basaglar offers equivalent clinical outcomes at reduced acquisition costs, delivering substantial savings for patients and health systems.
Guideline Endorsements
Major diabetes associations (ADA, AACE) include insulin glargine analogs as first‑line basal options for both type 1 and type 2 diabetes in their treatment algorithms.
Cost‑Saving Programs and Insurance Assistance
Manufacturer Co‑Pay Cards
Eligible patients can reduce copays to as low as $25 per month through manufacturer assistance. Enrollment is accessible via the Fit Life Pharmacy website.
Insurance Navigation
Our pharmacy specialists handle prior authorizations, formulary verification, and appeals to secure coverage and minimize delays.
In‑House Discount Programs
Stackable pharmacy coupons and multi‑month refill discounts amplify savings. Enroll in auto‑refill for additional pricing incentives and free shipping.
Patient Assistance Foundations
For uninsured or underinsured patients, we connect you to non‑profit foundations and grant programs to obtain free or low‑cost insulin.
Adherence Strategies and Patient Education
Pharmacist Consultations
Individualized coaching on injection technique, dose titration, and lifestyle integration ensures patients feel confident and supported.
Group Education Workshops
Interactive sessions cover basal‑bolus therapy, meal planning, and self‑monitoring techniques, fostering peer support and shared learning.
Digital Reminders and Logging
Customizable SMS/email alerts for dosing times, refill reminders, and upcoming appointments help keep therapy on track.
Printed & Video Resources
Easy‑to‑follow brochures, step‑by‑step injection videos, and troubleshooting guides empower patients to manage their Basaglar therapy independently.
Troubleshooting Common Issues
Air Bubbles
If bubbles persist after priming, hold pen upright, dial to 2 units, and expel until a solid column of insulin is present.
Pen Malfunction
If dialing stops before reaching your dose, check cartridge level; replace empty cartridges immediately to avoid missed doses.
Unexpected Hypoglycemia
Review injection timing, diet, and activity. Consider small basal dose reductions and always carry fast‑acting carbohydrates.
Injection Site Discomfort
Rotate sites meticulously, use fine‑gauge needles, and allow alcohol swabs to dry completely before injection.
Safety Information and Side Effects
Hypoglycemia
As with all insulin products, low blood sugar is the most common adverse effect. Recognize symptoms (sweating, trembling, confusion) and treat promptly with 15 g fast‑acting carbs.
Injection Site Reactions
Mild redness, itching, or swelling may occur. Monitor sites and rotate to prevent lipodystrophy.
Weight Gain
Improved glycemic control can lead to modest weight gain. Incorporate diet and exercise strategies to manage weight.
Lipodystrophy
Avoid repeated injections in the same spot. Rotate sites and inspect tissue regularly.
Allergic Reactions
Rare anaphylactic reactions require immediate discontinuation of insulin and emergency care.
Frequently Asked Questions
What if I miss a dose of Basaglar?
If remembered within 12 hours, administer immediately and continue with regular schedule. If more than 12 hours have passed, skip missed dose to avoid stacking—never double up.
Can Basaglar Cartridges be mixed with other insulins?
No. Insulin glargine must be injected separately to ensure its unique absorption profile is maintained.
How do I transition from another basal insulin to Basaglar?
A unit‑to‑unit conversion under medical supervision is typical. Monitor fasting glucose closely during transition and adjust dose as needed.
Is Basaglar safe during pregnancy?
Yes. Insulin glargine is widely used in gestational diabetes under obstetric and endocrine guidance. Doses often increase as pregnancy advances.
Ordering Basaglar Cartridges & Next Steps
At Fit Life Pharmacy, obtaining Basaglar Cartridges is simple and convenient:
Online Ordering
Visit our website, select Basaglar Cartridges, enter your savings code, and complete secure checkout.
Auto‑Refill Service
Enroll in our auto‑refill program for consistent delivery, SMS/email reminders, and discounted pricing.
In‑Store Pickup
Drop by any Fit Life Pharmacy location for same‑day pickup and pharmacist counseling.
Phone Orders
Call our dedicated diabetes line to place orders, check savings eligibility, and receive clinical support.
Your basal insulin therapy deserves the reliability, precision, and affordability of Basaglar Cartridges. Order today and let our expert team guide you toward steadier, safer blood sugar control—supporting your journey to better health one injection at a time.
Additional information
| Basaglar Cartridge - 100u/mL | 15mL, 30mL, 45mL, 60mL, 75mL |
|---|
Reviews
There are no reviews yet.